Prime Highlights
- Happy Health’s CEO shared his personal stroke and undiagnosed sleep apnea experience as motivation for building the platform.
- ARCH Venture Partners’ managing director said many diagnoses may never need to happen inside a hospital.
Key Facts
- Happy Health raised 75 million dollars in Series A funding led by ARCH Venture Partners and OpenLoop.
- The Happy Ring is the first FDA-cleared smart ring for multi-night at-home sleep testing.
Background
Digital health company Happy Health has secured a 75 million dollar Series A funding round to expand its artificial intelligence-powered platform for continuous, home-based healthcare. The round was led by ARCH Venture Partners and OpenLoop.
An ARCH Venture Partners managing director said healthcare has traditionally waited until people fall sick before acting, adding that Happy Health is proving many diagnoses may never need a hospital visit at all by combining continuous physiological monitoring with physician-guided care.
The Austin, Texas-based startup’s first application centres on sleep, which executives describe as one of the richest windows into human physiology. Its clinical-grade smart ring, called the Happy Ring, first received US Food and Drug Administration clearance in late 2024 and later gained approval for at-home sleep testing in mid-2025, making it the first FDA-cleared smart ring for multi-night sleep testing and round-the-clock biometrics.
The company’s sleep medicine platform includes a clinical care team of board-certified sleep physicians and is in-network with most major health insurance plans. Rather than comparing users to population averages, the platform builds an individual physiological baseline for each person, using sensors that collect over 2.8 million biometric measurements nightly. The device can diagnose obstructive sleep apnea, insomnia and related conditions within three nights with high accuracy, the company said.
Happy Health’s founder and CEO said the current healthcare system waits for people to become sick before acting, recalling his own stroke at age 24 followed by years of undiagnosed sleep apnea. He said the company was built to help physicians detect disease earlier and change how care is delivered.
